Global Gastrointestinal Therapeutics and Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Gastrointestinal Therapeutics and Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
Gastrointestinal Therapeutics and Diagnostics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastrointestinal Therapeutics and Diagnostics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastroenteritis and GI Bleeding are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastrointestinal Therapeutics and Diagnostics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastrointestinal Therapeutics and Diagnostics key companies include Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals and Takeda Pharmaceutical Company, etc. Abbott Laboratories, AstraZeneca, Eisai are top 3 players and held % share in total in 2022.
Gastrointestinal Therapeutics and Diagnostics can be divided into Diagnostics and Therapeutics, etc. Diagnostics is the mainstream product in the market, accounting for % share globally in 2022.
Gastrointestinal Therapeutics and Diagnostics is widely used in various fields, such as Gastroenteritis, GI Bleeding, Irritable Bowel Syndrome and Peptic Ulcer Disease (PUD), etc. Gastroenteritis provides greatest supports to the Gastrointestinal Therapeutics and Diagnostics industry development. In 2022, global % share of Gastrointestinal Therapeutics and Diagnostics went into Gastroenteritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastrointestinal Therapeutics and Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Segment by Type
Diagnostics
Therapeutics
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gastrointestinal Therapeutics and Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gastrointestinal Therapeutics and Diagnostics introduction, etc. Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Gastrointestinal Therapeutics and Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Gastrointestinal Therapeutics and Diagnostics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastrointestinal Therapeutics and Diagnostics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastroenteritis and GI Bleeding are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastrointestinal Therapeutics and Diagnostics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastrointestinal Therapeutics and Diagnostics key companies include Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals and Takeda Pharmaceutical Company, etc. Abbott Laboratories, AstraZeneca, Eisai are top 3 players and held % share in total in 2022.
Gastrointestinal Therapeutics and Diagnostics can be divided into Diagnostics and Therapeutics, etc. Diagnostics is the mainstream product in the market, accounting for % share globally in 2022.
Gastrointestinal Therapeutics and Diagnostics is widely used in various fields, such as Gastroenteritis, GI Bleeding, Irritable Bowel Syndrome and Peptic Ulcer Disease (PUD), etc. Gastroenteritis provides greatest supports to the Gastrointestinal Therapeutics and Diagnostics industry development. In 2022, global % share of Gastrointestinal Therapeutics and Diagnostics went into Gastroenteritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastrointestinal Therapeutics and Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gastrointestinal Therapeutics and Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gastrointestinal Therapeutics and Diagnostics introduction, etc. Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Gastrointestinal Therapeutics and Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices